NCT04234022 2026-04-09Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple MyelomaThe Royal Wolverhampton Hospitals NHS TrustRecruiting70 enrolled
NCT06163040 2025-07-31A Study to Evaluate the Safety of EmplicitiĀ® (Elotuzumab) When Treating Patients With Multiple Myeloma in TaiwanBristol-Myers SquibbCompleted7 enrolled